1𝘾𝙚𝙡𝙡.𝘼𝙞 𝙎𝙝𝙤𝙬𝙘𝙖𝙨𝙚𝙨 𝘽𝙧𝙚𝙖𝙠𝙩𝙝𝙧𝙤𝙪𝙜𝙝 𝙈𝙪𝙡𝙩𝙞-𝙊𝙢𝙞𝙘 𝙊𝙣𝙘𝙤𝙡𝙤𝙜𝙮 𝙄𝙣𝙨𝙞𝙜𝙝𝙩𝙨 𝘼𝙘𝙧𝙤𝙨𝙨 7 𝙎𝙩𝙪𝙙𝙞𝙚𝙨 𝙖𝙩 𝘼𝘼𝘾𝙍 2026
1Cell.Ai, a leader in precision oncology diagnostics, is proud to announce the presentation of seven research studies at the 𝘼𝙢𝙚𝙧𝙞𝙘𝙖𝙣
OneCell Diagnostics is now 1Cell.Ai
1Cell.Ai, a leader in precision oncology diagnostics, is proud to announce the presentation of seven research studies at the 𝘼𝙢𝙚𝙧𝙞𝙘𝙖𝙣
Collaboration integrates per-sample NGS internal standards with multi-omic precision oncology platform to enhance cancer diagnostics accuracy and access WILMINGTON, N.C.
FOSTER CITY, Calif., May 28, 2025 /PRNewswire/ — 1Cell.Ai, a precision oncology company developing advanced cell and molecular profiling platforms, announced the successful
FOSTER CITY, Calif. and DURHAM, N.C., April 24, 2025 /PRNewswire/ — 1Cell.Ai, a global leader in single cell precision diagnostics, has joined forces with BioSkryb Genomics,
AI-powered precision oncology leader to enhance early-stage clinical studies with the introduction of next-generation technology Foster City, CA. & Mumbai,